Page 70 - Read Online
P. 70

MacLennan et al. Mini-invasive Surg 2023;7:23  https://dx.doi.org/10.20517/2574-1225.2023.66  Page 5 of 5
               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2023.

               REFERENCES
               1.       Williamson PR, Altman DG, Bagley H, et al. The COMET handbook: version 1.0. Trials 2017;18:280.  DOI  PubMed  PMC
               2.       Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the journal of
                   clinical epidemiology. J Clin Epidemiol 2011;64:380-2.  DOI  PubMed
               3.       Egger  M,  Smith  GD,  Altman  DG.  Systematic  reviews  in  health  care:  meta-analysis  in  context.  Second  edition.  London:  BMJ
                   Publishing Group;  2001.  Available  from:  https://alraziuni.edu.ye/uploads/pdf/Systematic-Reviews-in-Health-Care-Meta-
                   Analysis-in-Context_2001.pdf. [Last accessed on 26 Jun 2023].
               4.       Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of
                   Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from: https://training.cochrane.org/ handbook#how-to-
                   access. [Last accessed on 26 Jun 2023].
               5.       MacLennan S, Williamson PR. The need for core outcome sets in urological cancer research. Transl Androl Urol 2021;10:2832-5.
                   DOI  PubMed  PMC
               6.       Dwan K, Gamble C, Williamson PR, Kirkham JJ; Reporting Bias Group. Systematic review of the empirical evidence of study
                   publication bias and outcome reporting bias - an updated review. PLoS One 2013;8:e66844.  DOI  PubMed  PMC
               7.       MacLennan S, Imamura M, Lapitan MC, et al; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel.
                   Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012;61:972-93.  DOI
                   PubMed
               8.       MacLennan S, Imamura M, Lapitan MC, et al; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel.
                   Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol
                   2012;62:1097-117.  DOI  PubMed
               9.       Rossi SH, Klatte T, Stewart GD. Quality of life outcomes in patients with localised renal cancer: a literature review. World J Urol
                   2018;36:1961-72.  DOI  PubMed  PMC
               10.      York C. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. Available from: https://www.york.ac.uk/media/
                   crd/Systematic_Reviews.pdf. [Last accessed on 26 Jun 2023].
               11.      Beyer K, Widdershoven C, Wintner LM, et al. A systematic review of heterogeneity in outcome definition and reporting in localised
                   renal cancer. Eur Urol Open Sci 2022;48:1-11.  DOI  PubMed  PMC
               12.      Kirkham JJ, Gorst S, Altman DG, et al. Core outcome set-standardised protocol items: the COS-STAP statement. Trials 2019;20:116.
                   DOI  PubMed  PMC
               13.      Kirkham JJ, Davis K, Altman DG, et al. Core outcome set-standards for development: the COS-STAD recommendations. PLoS Med
                   2017;14:e1002447.  DOI  PubMed  PMC
               14.      Beaton D, Maxwell L, Grosskleg S, et al. The OMERACT handbook. Available from: https://omeract.org/wp-content/uploads/2021/
                   12/OMERACT-Handbook-Chapter-Final-June_2_2021.pdf. [Last accessed on 26 Jun 2023].
               15.      Boers M, Tugwell P, Felson D, et al. World health organization and international league of associations for rheumatology core
                   endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9.
                   Available from: https://pubmed.ncbi.nlm.nih.gov/7799394/. [Last accessed on 26 Jun 2023].
               16.      Kirkham  JJ,  Clarke  M,  Williamson  PR.  A  methodological  approach  for  assessing  the  uptake  of  core  outcome  sets  using
                   clinicaltrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. BMJ 2017;357:j2262.  DOI  PubMed
                   PMC
               17.      Kirkham JJ, Boers M, Tugwell P, Clarke M, Williamson PR. Outcome measures in rheumatoid arthritis randomised trials over the last
                   50 years. Trials 2013;14:324.  DOI  PubMed  PMC
               18.      MacLennan S, Wintner LM, Beyer K, et al. A protocol for the development of core outcome sets for effectiveness trials and clinical
                   audits in renal cell cancer (R-COS). BJUI Compass 2023. Available from: https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/
                   bco2.266. [Last accessed on 26 Jun 2023].
               19.      Wintner LM, Gross F, Holzner B. Patient-reported outcome assessment in renal cell carcinoma: status quo and current developments.
                   Onkologie 2023:1-6.
               20.      Wintner L, Beisland E, Beisland C, Van Hemelrijck M, Holzner B. Development of an EORTC quality of life module for renal cell
                   cancer patients: phase I. Eur Psychiatry 2022;65:S756.  DOI
               21.      Khan  K.  The  CROWN  initiative:  journal  editors  invite  researchers  to  develop  core  outcomes  in  women’s  health.  BJOG
                   2014;121:1181-2.  DOI  PubMed
               22.      Prinsen CAC, Spuls PI, Kottner J, et al. Navigating the landscape of core outcome set development in dermatology. J Am Acad
                   Dermatol 2019;81:297-305.  DOI  PubMed
   65   66   67   68   69   70   71   72   73   74   75